Cambridge, MA, December 30, 1997 -- Procept, Inc. (Nasdaq: PRCT) today announced the election
of Mark C. Rogers, M.D. and Elliott H. Vernon to its Board of Directors, increasing the number of board
members from five to seven. Their appointments are effective immediately.
Dr. Mark Rogers, 55, has been Senior Vice President, Corporate Development and Chief Technology
Officer at The Perkin-Elmer Corporation since joining Perkin-Elmer in 1996. From 1992 to 1996, Dr.
Rogers was the Vice Chancellor for Health Affairs at Duke University Medical Center, and Executive
Director and Chief Executive Officer of Duke University Hospital and Health Network. Prior to his
employment at Duke, Dr. Rogers was on the faculty of Johns Hopkins University for 15 years where he
served as a Distinguished Faculty Professor and Chairman of the Department of Anesthesiology and
Critical Care Medicine, Associate Dean for Clinical Affairs, Director of the Pediatric Intensive Care Unit
and Professor of Pediatrics. Dr. Rogers is also a director of Discovery Laboratories, Inc. a publicly held
development-stage pharmaceutical company. Dr. Rogers received his M.D. from Upstate Medical
Center, State University of New York and has his M.B.A. from The Wharton School of Business. He
received his B.A. from Columbia University and held a Fulbright Scholarship.
Mr. Elliott Vernon, 54, has been the Chairman of the Board, President and Chief Executive Officer of
Healthcare Imaging Services, Inc., a publicly held operator of fixed-site magnetic resonance imaging
centers in the northeast, since its inception in 1991. For the past ten years, Mr. Vernon has also been
the managing partner of MR General Associates, a New Jersey general partnership which is the general
partner of DMR Associates, L.P., a Delaware limited partnership. Mr. Vernon was also one of the
founders of Transworld Nurses, Inc., the predecessor of Transworld HealthCare, Inc., a publicly held
regional supplier of a broad range of alternate site healthcare services and products. Mr. Vernon is also
a principal of Healthcare Financial Corp., LLC, a healthcare financial consulting company engaged
primarily in FDA matters. From January 1990 to December 1994, Mr. Vernon was a director, Executive
Vice President and General Counsel of Aegis Holdings Corporation, an international provider of financial
services through its investment management and capital markets consulting subsidiaries. Mr. Vernon is
currently a director of Pacific Pharmaceuticals, Inc. a publicly held company engaged in the
development and commercialization of medical products, focused primarily on cancer treatment.
oeDr. Rogers and Mr. Vernon bring extensive experience in the healthcare and business communities.
Procept will be able to utilize these talents as it accelerates its product development and corporate
partnering programs in 1998,Πsaid Stanley C. Erck, President and CEO of Procept.
Procept, Inc. is engaged in the research and development of small molecule therapeutics for the
prevention and treatment of chronic and life-threatening immune system disorders. Procept is developing
therapeutics for the treatment of autoimmune diseases, organ transplant rejection and infectious
diseases, such as AIDS and tuberculosis. Founded in 1985 and traded on the Nasdaq National Market
System under the symbol PRCT, Procept is located in Cambridge, Massachusetts. Procept press
releases are available on the internet at: procept.com. |
